Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants

S Reinke, A Thakur, C Gartlan, JS Bezbradica, A Milicic - Vaccines, 2020 - mdpi.com
In modern vaccines, adjuvants can be sophisticated immunological tools to promote robust
and long-lasting protection against prevalent diseases. However, there is an urgent need to …

[HTML][HTML] Molecular mechanisms of pyroptosis and its role in anti-tumor immunity

H Huang, Y Weng, W Tian, X Lin, J Chen… - International Journal of …, 2023 - ncbi.nlm.nih.gov
Pyroptosis is a form of cell death that is characterized by the destruction of the cell, and it has
implications in both the immune system and cancer immunotherapy. The gasdermin family is …

AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1–Bcl-6 axis-mediated B-cell differentiation

M Yang, D Long, L Hu, Z Zhao, Q Li, Y Guo… - … and Targeted Therapy, 2021 - nature.com
Abstract Absent in melanoma 2 (AIM2) has been reported to be a component of
inflammasomes in innate immune cells. Surprisingly, AIM2 is expressed by B cells, and …

Enhanced Cancer DNA Vaccine via Direct Transfection to Host Dendritic Cells Recruited in Injectable Scaffolds

TL Nguyen, Y Yin, Y Choi, JH Jeong, J Kim - Acs Nano, 2020 - ACS Publications
Deoxyribonucleic acid (DNA) vaccines are a promising cancer immunotherapy approach.
However, effective delivery of DNA to antigen-presenting cells (eg, dendritic cells (DCs)) for …

The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects

B Lu, JM Lim, B Yu, S Song, P Neeli… - Frontiers in …, 2024 - frontiersin.org
Vaccines have proven effective in the treatment and prevention of numerous diseases.
However, traditional attenuated and inactivated vaccines suffer from certain drawbacks such …

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond

R Wu, K Wang, Y Gai, M Li, J Wang, C Wang… - Journal of …, 2023 - Springer
The kidney is a vital organ responsible for maintaining homeostasis in the human body.
However, renal cell carcinoma (RCC) is a common malignancy of the urinary system and …

The complex role of AIM2 in autoimmune diseases and cancers

H Zhu, M Zhao, C Chang, V Chan… - Immunity, Inflammation …, 2021 - Wiley Online Library
Abstract Absent in melanoma 2 (AIM2) is a novel member of interferon (IFN)‐inducible
PYHIN proteins. In innate immune cells, AIM2 servers as a cytoplasmic double‐stranded …

Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression

H Mohammad, HW You, ST Kumbhar, KB Aher… - Journal of Drug Delivery …, 2024 - Elsevier
Renal cell carcinoma (RCC) records for 2% of all cancer assessments and mortality
worldwide, and its severity has more than doubled in the world over the last half-century …

Nanomedicine for combination urologic cancer immunotherapy

Y Tian, Z Liu, J Wang, L Li, F Wang, Z Zhu, X Wang - Pharmaceutics, 2023 - mdpi.com
Urologic cancers, particularly kidney, bladder, and prostate cancer, have a growing
incidence and account for about a million annual deaths worldwide. Treatments, including …

AIM2 inflammasome contributes to aldosterone-induced renal injury via endoplasmic reticulum stress

Y Wu, H Yang, S Xu, M Cheng, J Gu, W Zhang… - Clinical …, 2022 - portlandpress.com
Inflammatory response and renal fibrosis are the hallmarks of chronic kidney disease (CKD).
However, the specific mechanism of aldosterone-induced renal injury in the progress of …